Frank R. Lichtenberg
Columbia University
318 Uris Hall
3022 Broadway
New York, NY 10027
Tel: 212/854-4408
Fax: (212) 854-9895
E-Mail: 
WWW: http://www0.gsb.columbia.edu/faculty/flichtenberg/
NBER Program Affiliations:
PR
,
HC
NBER Affiliation: Research Associate
Institutional Affiliation: Columbia University
Information about this author at RePEc
NBER Working Papers and Publications
January 2019 | How Many Life-Years Have New Drugs Saved? A 3-Way Fixed-Effects Analysis of 66 Diseases in 27 Countries, 2000-2013
w25483
Published: "How many life-years have new drugs saved? A three-way fixed-effects analysis of 66 diseases in 27 countries, 2000–2013." International Health, March 2019
|
December 2018 | The Long-run Impact of New Medical Ideas on Cancer Survival and Mortality
w25328
Published: "The long-run impact of new medical ideas on cancer survival and mortality," Economics of Innovation and New Technology, December 2018
|
May 2018 | The Value of Cytochrome P450 2C19 Pharmacogenomic Information for Patients Receiving Clopidogrel Therapy Following a Major Cardiovascular Event: Evidence from Geisinger
with Rebecca A. Pulk, Jove Graham, Daniel Maeng, Marc S. Williams, Eric Wright
in Economic Dimensions of Personalized and Precision Medicine, Ernst R. Berndt, Dana P. Goldman, and John W. Rowe, editor
|
April 2018 | The Impact of New Drug Launches on Life-Years Lost in 2015 from 19 Types of Cancer in 36 Countries
w24536
Published: Frank R. Lichtenberg, 2018. "THE IMPACT OF NEW DRUG LAUNCHES ON LIFE-YEARS LOST IN 2015 FROM 19 TYPES OF CANCER IN 36 COUNTRIES," Journal of Demographic Economics, vol 84(03), pages 309-354.
|
March 2017 | The Impact of Public and Private Research Support on Premature Cancer Mortality and Hospitalization in the U.S., 1999-2013
w23241
Published: "The Impact of Public and Private Research on Premature Cancer Mortality and Hospitalization in the United States, 1999-2013." The American Economist 63 (2): 147-165
|
October 2016 | The Impact of Biomedical Research on U.S. Cancer Mortality: A Bibliometric Analysis
in Measuring and Modeling Health Care Costs, Ana Aizcorbe, Colin Baker, Ernst R. Berndt, and David M. Cutler, editors
|
December 2015 | Listen to your Doctor, or else!: Medication Under-use and Overuse and Long-term Health Outcomes of Danish Diabetes Patients
with Gisela Hostenkamp: w21780
|
June 2015 | The Impact of Pharmaceutical Innovation on Premature Cancer Mortality in Canada, 2000-2011
w21239
Published:
|
October 2013 | The Impact of Biomedical Knowledge Accumulation on Mortality: A Bibliometric Analysis of Cancer Data
w19593
|
November 2012 | The Effect of Pharmaceutical Innovation on Longevity: Patient-Level Evidence from the 1996-2002 Medical Expenditure Panel Survey and Linked Mortality Public-Use Files
w18552
Published: Lichtenberg Frank R., 2013. "The Effect of Pharmaceutical Innovation on Longevity: Patient Level Evidence from the 1996â2002 Medical Expenditure Panel Survey and Linked Mortality Public-use Files," Forum for Health Economics & Policy, De Gruyter, vol. 16(1), pages 1-33, January. citation courtesy of 
|
July 2012 | Pharmaceutical Innovation and Longevity Growth in 30 Developing and High-income Countries, 2000-2009
w18235
Published: Health Policy and Technology Volume 3, Issue 1, March 2014, Pages 36–58
|
January 2012 | The Effect of Pharmaceutical Innovation on the Functional Limitations of Elderly Americans Evidence from the 2004 National Nursing Home Survey
w17750
Published: Frank R. Lichtenberg (2012), The Effect of Pharmaceutical Innovation on the Functional Limitations of Elderly Americans: Evidence from the 2004 National Nursing Home Survey, in Kristian Bolin, Robert Kaestner (ed.) The Economics of Medical Technology (Advances in Health Economics and Health Services Research, Volume 23) Emerald Group Publishing Limited, pp.73 - 101
|
September 2011 | The Impact of Therapeutic Procedure Innovation on Hospital Patient Longevity: Evidence from Western Australia, 2000-2007
w17414
Published: Lichtenberg, Frank R., 2013. "The impact of therapeutic procedure innovation on hospital patient longevity: Evidence from Western Australia, 2000â2007," Social Science & Medicine, Elsevier, vol. 77(C), pages 50-59. citation courtesy of 
|
August 2010 | Are the More Educated More LIkely to Use New Drugs?
with Adriana Lleras-Muney
in Contributions in Memory of Zvi Griliches, Jacques Mairesse and Manuel Trajtenberg, editors
|
June 2010 | Are Increasing 5-Year Survival Rates Evidence of Success Against Cancer? A reexamination using data from the U.S. and Australia
w16051
Published: Frank R. Lichtenberg, 2010.
"Are Increasing 5-Year Survival Rates Evidence of Success Against Cancer? A Reexamination Using Data from the U.S. and Australia,"
Forum for Health Economics & Policy,
Berkeley Electronic Press, vol. 13(2).
citation courtesy of 
|
April 2010 | Has medical innovation reduced cancer mortality?
w15880
Published: “Has Medical Innovation Reduced Cancer Mortality?,” CESifo Economic Studies, published online 14 November 2013. citation courtesy of 
|
June 2009 | The Quality of Medical Care, Behavioral Risk Factors, and Longevity Growth
w15068
Published: Frank Lichtenberg, 2011. "The quality of medical care, behavioral risk factors, and longevity growth," International Journal of Health Care Finance and Economics, Springer, vol. 11(1), pages 1-34, March. citation courtesy of 
|
May 2008 | Have Newer Cardiovascular Drugs Reduced Hospitalization? Evidence From Longitudinal Country-Level Data on 20 OECD Countries, 1995-2003
w14008
Published: Frank R. Lichtenberg, 2009. "Have newer cardiovascular drugs reduced hospitalization? Evidence from longitudinal country-level data on 20 OECD countries, 1995-2003," Health Economics, John Wiley & Sons, Ltd., vol. 18(5), pages 519-534. citation courtesy of 
|
| Pharmaceutical innovation and the longevity of Australians: a first look
with Gautier Duflos: w14009
|
December 2007 | Pharmaceutical Innovation and U.S. Cancer Survival, 1992-2003: Evidence from Linked SEER-MEDSTAT Data
in Frontiers in Health Policy Research, Volume 10, David Cutler, Alan Garber, and Dana Goldman, organizers
|
September 2006 | Importation and Innovation
w12539
Published: Frank R. Lichtenberg, 2007. "Importation And Innovation," Economics of Innovation and New Technology, Taylor and Francis Journals, vol. 16(6), pages 403-417. citation courtesy of 
|
August 2006 | The Impact of Increased Utilization of HIV Drugs on Longevity and Medical Expenditures: An Assessment Based on Aggregate U.S. Time-Series Data
w12406
Published: Frank R Lichtenberg, 2006. "The impact of increased utilization of HIV drugs on longevity and medical expenditure: an assessment based on aggregate US time-series data," Expert Review of Pharmacoeconomics & Outcomes Research, vol 6(4), pages 425-436.
|
March 2006 | The Impact of New Laboratory Procedures and Other Medical Innovations on the Health of Americans, 1990-2003: Evidence from Longitudinal, Disease-Level Data
w12120
Published: Frank R. Lichtenberg, 2007. "The Impact of New Drugs on US Longevity and Medical Expenditure, 1990–2003: Evidence from Longitudinal, Disease-Level Data," American Economic Review, American Economic Association, vol. 97(2), pages 438-443, May.
|
August 2005 | Pharmaceutical Knowledge-Capital Accumulation and Longevity
in Measuring Capital in the New Economy, Carol Corrado, John Haltiwanger and Dan Sichel, editors
|
November 2004 | The Effect of Drug Vintage on Survival: Micro Evidence from Puerto Rico's Medicaid Program
w10884
|
February 2004 | The Expanding Pharmaceutical Arsenal in the War on Cancer
w10328
|
June 2003 | Does Misery Love Company? Evidence from pharmaceutical markets before and after the Orphan Drug Act
with Joel Waldfogel: w9750
|
| The impact of new drug launches on longevity: evidence from longitudinal disease-level data from 52 countries, 1982-2001
w9754
Published:
- Frank R. Lichtenberg, 2005. "The Impact of New Drug Launches on Longevity: Evidence from Longitudinal, Disease-Level Data from 52 Countries, 1982?2001," International Journal of Health Care Finance and Economics, vol 5(1), pages 47-73.
- Frank Lichtenberg, 2005. "The Impact of New Drug Launches on Longevity: Evidence from Longitudinal, Disease-Level Data from 52 Countries, 1982–2001," International Journal of Health Economics and Management, Springer, vol. 5(1), pages 47-73, January. citation courtesy of
|
December 2002 | New Drugs: Health and Economic Impacts
NBER Reporter Winter 03
|
November 2002 | Pharmaceutical-embodied technical progress, longevity, and quality of life: drugs as "equipment for your health"
with Suchin Virabhak: w9351
Published: Frank R. Lichtenberg & Suchin Virabhak, 2007. "Pharmaceutical-embodied technical progress, longevity, and quality of life: drugs as 'Equipment for Your Health'," Managerial and Decision Economics, John Wiley & Sons, Ltd., vol. 28(4-5), pages 371-392. citation courtesy of 
|
| The Dual Effects of Intellectual Property Regulations: Within- and Between- Patent Competition in the US Pharmaceuticals Industry
with Tomas J. Philipson: w9303
Published: Litchenberg, Frank R. and Tomas Philipson. “The Dual Effects of Intellectual Property Regulations: Within- and Between-Patent Competition in The US Pharmaceuticals Industry." Journal of Law & Economics 45 (2002): 643-672. citation courtesy of 
|
September 2002 | The Effect of Changes in Drug Utilization on Labor Supply and Per Capita Output
w9139
|
| The Effect of Education on Medical Technology Adoption: Are the More Educated More Likely to Use New Drugs
with Adriana Lleras-Muney: w9185
Published: Lleras-Muney, Adriana and Frank Lichtenberg. “The Effect Of Education On Medical Technology Adoption: Are The More Educated More Likely To Use New Drugs?" Annales d’Economie et Statistique in memory of Zvi Griliches 79/80 (2006).
|
June 2002 | Benefits and Costs of Newer Drugs: An Update
w8996
Published: Frank R. Lichtenberg, 2007. "Benefits and costs of newer drugs: an update," Managerial and Decision Economics, John Wiley & Sons, Ltd., vol. 28(4-5), pages 485-490. citation courtesy of 
|
January 2002 | Sources of U.S. Longevity Increase, 1960-1997
w8755
Published: Lichtenberg, Frank R. "Sources Of U.S. Longevity Increase, 1960-2001," Quarterly Review of Economics and Finance, 2004, v44(3,Jul), 369-389.
|
| The Effects of Medicare on Health Care Utilization and Outcomes
in Frontiers in Health Policy Research, Volume 5, Alan M. Garber, editor
|
December 2001 | The Effect of New Drugs on Mortality from Rare Diseases and HIV
w8677
|
March 2001 | The Benefits and Costs of Newer Drugs: Evidence from the 1996 Medical Expenditure Panel Survey
w8147
Published: Frank R. Lichtenberg, 2007. "Benefits and costs of newer drugs: an update," Health Economics, John Wiley & Sons, Ltd., vol. 28(4-5), pages 485-490.
|
January 2001 | The Allocation of Publicly Funded Biomedical Research
in Medical Care Output and Productivity, David M. Cutler and Ernst R. Berndt, editors
|
June 1998 | The Allocation of Publicly-Funded Biomedical Research
w6601
|
May 1998 | Pharmaceutical Innovation, Mortality Reduction, and Economic Growth
w6569
Published: Murphy, Kevin M. and Robert H. Topel (eds.) Measuring the Gains from Medical Research: An Economic Approach. Chicago: University of Chicago Press, 2003.
|
May 1997 | The Impact and Organization of Publicly-Funded Research and Development in the European Community
with Maryann P. Feldman: w6040
Published: Maryann P. Feldman & Frank R. Lichtenberg, 1998. "The Impact and Organization of Publicly-Funded Research and development in the European Community," Annales d'Economie et de Statistique, ADRES, issue 49-50, pages 08, Janvier-J. citation courtesy of 
|
July 1996 | International R&D Spillovers: A Re-Examination
with Bruno van Pottelsberghe de la Potterie: w5668
Published: Published as "International R&D Spillovers: A Comment", European Economic Review, Vol. 42, no. 8 (September 1998): 1483-1491.
|
June 1996 | The Effect of New Political Administration on Federal Government Productivity and Employment
w5601
Published:
- Published as "The Effect of Government Funding on Private Industrial Research and Development: A Re-Assessment", JINDE, Vol. 36, no. 1 (1987): 97-104. With Donald Siegel, published as "The Effect of Control Changes on the
- Productivity of U.S. Manufacturing Plants", JACF, Vol. 2, no. 2 (1989): 60- 67.
|
| Computer Use and Productivity Growth in Federal Government Agencies, 1987 to 1992
with William Lehr: w5616
Published: Published as "Computer Use and Productivity Growth in US Federal Government Agencies, 1987-92", JINDE, Vol. 46, no. 2 (June 1998): 257-279.
|
January 1996 | The Effect of Pharmaceutical Utilization and Innovation on Hospitalization and Mortality
w5418
Published:
- Published as "The Effect of Government Funding on Private Industrial Research and Development: A Re-Assessment", JINDE, Vol. 36, no. 1 (1987): 97-104. With Donald Siegel, published as "The Effect of Control Changes on the
- Productivity of U.S. Manufacturing Plants", JACF, Vol. 2, no. 2 (1989): 60-67.
|
November 1993 | The Output Contributions of Computer Equipment and Personnel: A Firm- Level Analysis
w4540
Published: Economics of Innovation and New Technology, vol. 3, pp. 201-217, 1995
|
September 1992 | R&D Investment and International Productivity Differences
w4161
Published: Economic Growth in the World Economy, Symposium 1992, edited by Horst Siebert, pp. 89-110.
|
June 1992 | Ownership Structure and Corporate Performance in Japan
with George M. Pushner: w4092
Published: Japan and the World Economy, vol. 6, (1994) pp. 239-261. citation courtesy of 
|
December 1991 | Labor Market Institutions, Liquidity Constraints, and Macroeconomic Stability
w3926
Published: Journal of Economic Behavior and Organization, vol. 28, no. 1, (September 1995), pp. 145-154 citation courtesy of 
|
January 1990 | Industrial De-Diversification and its Consequences for Productivity
w3231
Journal of Economic Behavior and Organization, December 1992, forthcoming. citation courtesy of 
|
December 1989 | The Effects of Mergers on Prices, Costs, and Capacity Utilization in the U.S. Air Transportation Industry, 1970-84
with Moshe Kim: w3197
Frank Lichtenberg, author, Corporate Takeovers and Productivity. Cambridge: MIT Press, forthcoming 1992, Chapter 8.
|
July 1989 | How Elastic is the Government's Demand for Weapons?
w3025
Published: Journal of Public Economics, Vol. 40, pp. 57-78, (1989). citation courtesy of 
|
June 1989 | Productivity and Changes in Ownership of Manufacturing Plants
with Donald Siegel: r1208
Published: Brookings Papers on Economic Activity, Vol. 3, pp. 643-673, (1987).
|
| The Effects of Leveraged Buyouts on Productivity and Related Aspects of Firm Behavior
with Donald Siegel: w3022
Published: Journal of Financial Economics, Vol. 27, No. 1, pp. 165-194, (September 1990). citation courtesy of 
|
March 1989 | The Effect of Takeovers on the Employment and Wages of Central-Office and Other Personnel
with Donald Siegel: w2895
Published: "The Effect of Ownership Change on the Employment and Wages of Central-Office and Other Personnel," Journal of Law and Economics, Vol. XXXIII, pp. 383-408, (October 1990).
|
| The Impact of R&D Investment On Productivity - New Evidence Using Linked R&D-LRD Data
with Donald Siegel: w2901
Published: Economic Inquiry, Vol. 29 No.2, pp. 203-229, (April 1991). citation courtesy of 
|
October 1988 | Technical Change, Learning, and Wages
with Ann P. Bartel: w2732
Published: "The Age of Technology and Its Impact on Employee Wages." From Economics of Innovation and New Technology, Vol. 1, pp. 215-231, (1991).
|
| Government Subsidies to Private Military R&D Investment: DOD's IR&D Policy
w2745
Published: Defense Economics, Vol. 1, pp. 149-158, (1990).
|
September 1988 | IR&D Project Data and Theories of R&D Investment
w2720
Published: "IR&D Projected Data and Theories of R&D Investment." From Journal of Economic Dynamics and Control, Vol. 13, pp. 271-282, (1989).
|
August 1986 | Errors of Measurement in Output Deflators
with Zvi Griliches: w2000
Published: Journal of Business & Economic Statistics, Vol. 7, No. 1, pp. 1-9,(January 1989). citation courtesy of 
|
July 1986 | Private Investment in R&D to Signal Ability to Perform Government Contracts
w1974
Published: "The Private R&D Investment Response to Federal Design and Technical Competitions". From The American Economic Review, Vol. 78, No. 3, (June 1988).
|
October 1985 | The Comparative Advantage of Educated Workers in Implementing New Technology: Some Empirical Evidence
with Ann P. Bartel: w1718
Published: Bartel, Ann P. and Frank R. Lichtenberg."The Comparative Advantage of Educated Workers in Implementing New Technology: Some Empirical Evidence,"Review of Economics and Statistics, Vol. LXIX, No. 1, February 1987, pp. 1-11.
|
November 1984 | Interindustry Technology Flows and Productivity Growth: A Reexamination
with Zvi Griliches: r0542
Published: Griliches, Zvi and Frank Lichtenberg. "Interindustry Technology Flows and Productivity Growth: A Reexamination." The Review of Economics and Statistics, Vol. 66, No. 2, (May 1984), pp. 324-329.
|
1984 | R&D and Productivity Growth at the Industry Level: Is There Still a Relationship?
with Zvi Griliches
in R&D, Patents, and Productivity, Zvi Griliches, editor
|
February 1982 | R and D and Productivity at the Industry Level: Is There Still a Relationship?
with Zvi Griliches: w0850
Published: Griliches, Zvi and Frank Lichtenberg. "R&D and Productivity Growth at the Industry Level: Is There Still a Relationship?" R&D, Patents and Productivity, edited by Zvi Griliches. Chicago: University of Chicago Press, (1984). pp. 465-496.
|
May 1981 | Training, Tenure, and Productivity
w0671
|
|
|